Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Total 13F shares
-
46,444,969
-
Share change
-
+815,954
-
Total reported value
-
$6,148,068,684
-
Put/Call ratio
-
106%
-
Price per share
-
$132.37
-
Number of holders
-
388
-
Value change
-
+$102,643,125
-
Number of buys
-
181
-
Number of sells
-
176
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2019
As of 30 Sep 2019,
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) was held by
388 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,444,969 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., AQR CAPITAL MANAGEMENT LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, STATE STREET CORP, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, TimesSquare Capital Management, LLC, and Bank of New York Mellon Corp.
This page lists
389
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.